Vistin Pharma ASA reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was NOK 106.73 million compared to NOK 68.99 million a year ago. Net income was NOK 7.1 million compared to NOK 0.242 million a year ago. Basic earnings per share from continuing operations was NOK 0.16 compared to NOK 0.01 a year ago. Diluted earnings per share from continuing operations was NOK 0.16 compared to NOK 0.01 a year ago.
For the six months, sales was NOK 207.67 million compared to NOK 102.21 million a year ago. Net income was NOK 4.12 million compared to net loss of NOK 14.91 million a year ago. Basic earnings per share from continuing operations was NOK 0.09 compared to basic loss per share from continuing operations of NOK 0.34 a year ago. Diluted earnings per share from continuing operations was NOK 0.09 compared to diluted loss per share from continuing operations of NOK 0.34 a year ago.